The Possibilities of Drug Prevention of Diabetes Mellitus Type 2

V.I. Pankiv


Over the past few years there have been several randomized controlled trials that examine the effect of lifestyle modification and pharmacological interventions on the likelihood of developing diabetes mellitus (DM) type 2 in people at high risk. These studies demonstrated that the number of people newly diagnosed with diabetes within 3–6-year period may be considerably reduced. Therefore focus of discussing the tactics to control DM type 2 is shifted from the relatively narrow topic of treatment of the disease at a wide range of issues of its prophylaxis: prevention of development and early treatment of DM, aimed to stabilization or reverse progression of the disease and prevention of its progression. This review discusses the general concept and the evidence base on preventing DM type 2 in the context of the pathogenesis of the disease. In addition, the attention is paid to the possibilities of the use of the discussed approaches to clinical practice, taking into account pathogenetic features of the disease and and clinical findings.


diabetes mellitus; type 2; prevention


Генделека Г.Ф. Превентивная диабетология. Белая книга профилактики сахарного диабета 2-го типа и его осложнений. — Одесса: ВМВ, 2013. — 608 с.

Дедов И.И. Сахарный диабет: развитие технологий в диагностике, лечении и профилактике (пленарная лекция) // Сахарный диабет. — 2010. — № 3. — C. 6-13.

Buchanan T.A. (How) can we prevent type 2 diabetes? // Diabetes. — 2007. — Vol. 56. — P. 1502-1507.

Lie M.L., Hayes L., Lewis-Barned N.J. et al. Preventing Type 2 diabetes after gestational diabetes: women’s experiences and implications for diabetes prevention interventions // Diabet. Med. — 2013. — Vol. 30 (8). — P. 986-993.

Ramachandran A., Snehalatha C., Samith Shetty A., Nanditha A. Primary prevention of Type 2 diabetes in South Asians — challenges and the way forward // Diabet. Med. — 2013. — Vol. 30 (1). — P. 26-34.

Albright A.L., Gregg E.W. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program // Am. J. Prev. Med. — 2013. — Vol. 44. — P. 346-351.

Taylor J., Cottrell C., Chatterton H. et al. Identifying risk and preventing progression to Type 2 diabetes in vulnerable and disadvantaged adults: a pragmatic review // Diabet. Med. — 2013. — Vol. 30 (1). — P. 16-25.

Bartz S., Freemark M. Pathogenesis and prevention of type 2 diabetes: parental determinants, breastfeeding, and early childhood nutrition // Curr. Diab. Rep. — 2012. — Vol. 12 (1). — P. 82-87.

Lazarou C., Panagiotakos D., Matalas A.L. The role of diet in prevention and management of type 2 diabetes: implications for public health // Crit. Rev. Food Sci. Nutr. — 2012. — Vol. 52 (5). — P. 382-389.

Backholer K., Peeters A., Herman W.H. et al. Diabetes Prevention and Treatment Strategies: are we doing enough? // Diabetes Care. — 2013. — Vol. 36. — P. 2714-2719.

Diabetes Prevention Program Research Group: reduction in the evidence of type 2 diabetes with lifestyle intervention or metformin // N. Engl. J. Med. — 2002. — Vol. 346. — P. 393-403.

The Diabetes Prevention Program Research Group: Diabetic Prevalence and Its Risk Factors in China, 1994 // J. Chinese Med. — 1997. — Vol. 36. — P. 384-389.

Chiasson J.-L., Josse R., Gomis R. et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial // Lancet. — 2002. — Vol. 359. — P. 2072-2077.

Dunbar J., Hernan A., Janus E. et al. Melbourne Diabetes Prevention Study research group. Implementation salvage experiences from the Melbourne diabetes prevention study // BMC Public Health. — 2012. — Vol. 12. — 806 p.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© "Publishing House "Zaslavsky", 1997-2020


   Seo анализ сайта